
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $366.3M | $670.5M | $801.5M | $632.4M | $634.4M | |
Revenue Growth (YoY) | 35.53% | 83.08% | 19.54% | -21.11% | 0.33% | |
Cost of Revenues | $156.6M | $279.3M | $345.8M | $353.9M | $359.8M | |
Gross Profit | $209.6M | $391.3M | $455.7M | $278.4M | $274.6M | |
Gross Profit Margin | 57.23% | 58.35% | 56.85% | 44.03% | 43.29% | |
R&D Expenses | $20.2M | $34.3M | $43.9M | $42.7M | $43.2M | |
Selling, General & Admin | $119.6M | $183.9M | $215.8M | $218.6M | $263.4M | |
Other Inc / (Exp) | $1.5M | -$6.9M | $26.2M | $50.2M | $27.5M | |
Operating Expenses | $139.8M | $218.1M | $259.8M | $261.3M | $306.6M | |
Operating Income | $69.8M | $173.1M | $195.9M | $17.1M | -$31.9M | |
Net Interest Expenses | $12.1M | $12.7M | $3M | $10.6M | $22.6M | |
EBT. Incl. Unusual Items | $59.2M | $153.5M | $219.1M | $56.7M | -$27M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$709K | $25.3M | $33.2M | $21.1M | -$1.5M | |
Net Income to Company | $59.9M | $128.3M | $186M | $35.6M | -$25.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $59.9M | $128.3M | $186M | $35.6M | -$25.5M | |
Basic EPS (Cont. Ops) | $1.14 | $2.33 | $3.35 | $0.64 | -$0.46 | |
Diluted EPS (Cont. Ops) | $1.11 | $2.24 | $3.24 | $0.63 | -$0.46 | |
Weighted Average Basic Share | $52.6M | $55M | $55.5M | $55.7M | $55.9M | |
Weighted Average Diluted Share | $53.9M | $57.3M | $57.5M | $56.4M | $55.9M | |
EBITDA | $97.1M | $203.3M | $277.3M | $145.3M | $80.3M | |
EBIT | $70M | $164.8M | $220.3M | $59.2M | -$6.3M | |
Revenue (Reported) | $366.3M | $670.5M | $801.5M | $632.4M | $634.4M | |
Operating Income (Reported) | $69.8M | $173.1M | $195.9M | $17.1M | -$31.9M | |
Operating Income (Adjusted) | $70M | $164.8M | $220.3M | $59.2M | -$6.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $142.8M | $206.4M | $165.4M | $153.2M | $169.2M | |
Revenue Growth (YoY) | 87.72% | 44.5% | -19.87% | -7.38% | 10.44% | |
Cost of Revenues | $59.7M | $82.4M | $81.8M | $76.4M | $78.4M | |
Gross Profit | $83.1M | $124M | $83.5M | $76.8M | $90.8M | |
Gross Profit Margin | 58.17% | 60.1% | 50.51% | 50.13% | 53.65% | |
R&D Expenses | $7.6M | $12.2M | $12.2M | $11.2M | $12.9M | |
Selling, General & Admin | $39.1M | $54.3M | $56.3M | $61.8M | $71.3M | |
Other Inc / (Exp) | -$172K | $2.1M | $4.3M | $5.5M | $7M | |
Operating Expenses | $46.7M | $66.5M | $68.4M | $73M | $84.2M | |
Operating Income | $36.4M | $57.6M | $15.1M | $3.8M | $6.6M | |
Net Interest Expenses | $3.1M | $744K | $865K | $5.5M | $5.7M | |
EBT. Incl. Unusual Items | $33.1M | $58.9M | $18.6M | $3.7M | $7.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $3.7M | $12M | $3.2M | $399K | $2.1M | |
Net Income to Company | $29.5M | $47M | $15.3M | $3.3M | $5.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $29.5M | $47M | $15.3M | $3.3M | $5.8M | |
Basic EPS (Cont. Ops) | $0.54 | $0.85 | $0.28 | $0.06 | $0.10 | |
Diluted EPS (Cont. Ops) | $0.52 | $0.81 | $0.27 | $0.06 | $0.10 | |
Weighted Average Basic Share | $54.8M | $55.4M | $55.6M | $55.8M | $56.1M | |
Weighted Average Diluted Share | $56.9M | $58.8M | $57M | $56.5M | $56.6M | |
EBITDA | $44.3M | $71.1M | $34.3M | $30M | $36.4M | |
EBIT | $35.9M | $59.2M | $19M | $8.7M | $13.2M | |
Revenue (Reported) | $142.8M | $206.4M | $165.4M | $153.2M | $169.2M | |
Operating Income (Reported) | $36.4M | $57.6M | $15.1M | $3.8M | $6.6M | |
Operating Income (Adjusted) | $35.9M | $59.2M | $19M | $8.7M | $13.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $433M | $734.1M | $760.5M | $620.2M | $650.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $184.4M | $301.9M | $345.3M | $348.5M | $361.8M | |
Gross Profit | $248.6M | $432.2M | $415.2M | $271.7M | $288.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $23.1M | $38.8M | $43.9M | $41.8M | $44.9M | |
Selling, General & Admin | $131.2M | $199.1M | $217.8M | $224.1M | $272.8M | |
Other Inc / (Exp) | -$391K | -$4.6M | $28.4M | $51.3M | $29M | |
Operating Expenses | $154.3M | $237.9M | $261.8M | $265.9M | $317.7M | |
Operating Income | $94.3M | $194.3M | $153.4M | $5.8M | -$29.1M | |
Net Interest Expenses | $12.3M | $10.4M | $3.1M | $15.2M | $22.7M | |
EBT. Incl. Unusual Items | $81.6M | $179.4M | $178.8M | $41.8M | -$22.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.1M | $33.6M | $24.4M | $18.3M | $193K | |
Net Income to Company | $79.6M | $145.8M | $154.3M | $23.6M | -$23M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $79.6M | $145.8M | $154.3M | $23.6M | -$23M | |
Basic EPS (Cont. Ops) | $1.49 | $2.65 | $2.79 | $0.26 | -$0.41 | |
Diluted EPS (Cont. Ops) | $1.45 | $2.53 | $2.71 | $0.25 | -$0.41 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $121.3M | $230M | $240.6M | $141M | $86.6M | |
EBIT | $92.2M | $188.2M | $180M | $49M | -$1.8M | |
Revenue (Reported) | $433M | $734.1M | $760.5M | $620.2M | $650.4M | |
Operating Income (Reported) | $94.3M | $194.3M | $153.4M | $5.8M | -$29.1M | |
Operating Income (Adjusted) | $92.2M | $188.2M | $180M | $49M | -$1.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $142.8M | $206.4M | $165.4M | $153.2M | $169.2M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $59.7M | $82.4M | $81.8M | $76.4M | $78.4M | |
Gross Profit | $83.1M | $124M | $83.5M | $76.8M | $90.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $7.6M | $12.2M | $12.2M | $11.2M | $12.9M | |
Selling, General & Admin | $39.1M | $54.3M | $56.3M | $61.8M | $71.3M | |
Other Inc / (Exp) | -$172K | $2.1M | $4.3M | $5.5M | $7M | |
Operating Expenses | $46.7M | $66.5M | $68.4M | $73M | $84.2M | |
Operating Income | $36.4M | $57.6M | $15.1M | $3.8M | $6.6M | |
Net Interest Expenses | $3.1M | $744K | $865K | $5.5M | $5.7M | |
EBT. Incl. Unusual Items | $33.1M | $58.9M | $18.6M | $3.7M | $7.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $3.7M | $12M | $3.2M | $399K | $2.1M | |
Net Income to Company | $29.5M | $47M | $15.3M | $3.3M | $5.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $29.5M | $47M | $15.3M | $3.3M | $5.8M | |
Basic EPS (Cont. Ops) | $0.54 | $0.85 | $0.28 | $0.06 | $0.10 | |
Diluted EPS (Cont. Ops) | $0.52 | $0.81 | $0.27 | $0.06 | $0.10 | |
Weighted Average Basic Share | $54.8M | $55.4M | $55.6M | $55.8M | $56.1M | |
Weighted Average Diluted Share | $56.9M | $58.8M | $57M | $56.5M | $56.6M | |
EBITDA | $44.3M | $71.1M | $34.3M | $30M | $36.4M | |
EBIT | $35.9M | $59.2M | $19M | $8.7M | $13.2M | |
Revenue (Reported) | $142.8M | $206.4M | $165.4M | $153.2M | $169.2M | |
Operating Income (Reported) | $36.4M | $57.6M | $15.1M | $3.8M | $6.6M | |
Operating Income (Adjusted) | $35.9M | $59.2M | $19M | $8.7M | $13.2M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $717.3M | $603.8M | $523.5M | $751.3M | $757.4M | |
Short Term Investments | -- | -- | $100.3M | -- | -- | |
Accounts Receivable, Net | $71.4M | $117.4M | $116.2M | $124.2M | $134.1M | |
Inventory | $95M | $184.5M | $238.3M | $202.3M | $143M | |
Prepaid Expenses | $4.6M | $6.7M | $2.4M | $13.6M | $11M | |
Other Current Assets | $14.1M | $19.3M | $17.4M | $19.9M | $20.6M | |
Total Current Assets | $902.4M | $931.7M | $998.1M | $1.1B | $1.1B | |
Property Plant And Equipment | $92M | $226.5M | $315.7M | $323M | $333.1M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $618.3M | $860.4M | $855.5M | $987.1M | $1B | |
Other Intangibles | $287.1M | $337.3M | $360.6M | $407M | $397.9M | |
Other Long-Term Assets | $573K | $615K | $815K | $1.3M | $868K | |
Total Assets | $1.9B | $2.4B | $2.5B | $2.8B | $2.8B | |
Accounts Payable | $16.9M | $36.2M | $27.6M | $19.6M | $32.1M | |
Accrued Expenses | $16.1M | $13.7M | $15.9M | $16.8M | $15.6M | |
Current Portion Of Long-Term Debt | $243.7M | $255.3M | $284.6M | $69.5M | -- | |
Current Portion Of Capital Lease Obligations | $5.3M | $8.3M | $7M | $5.6M | $15.1M | |
Other Current Liabilities | -- | -- | $14M | $13M | $17.1M | |
Total Current Liabilities | $319M | $375.3M | $404.2M | $164.9M | $126.8M | |
Long-Term Debt | -- | -- | -- | $510.1M | $525.6M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $373.7M | $608.3M | $620.9M | $866.3M | $856.9M | |
Common Stock | $548K | $553K | $556K | $558K | $561K | |
Other Common Equity Adj | $2.1M | -- | -$34.4M | -$37.8M | -$52.5M | |
Common Equity | $1.5B | $1.8B | $1.9B | $2B | $2B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $1.5B | $1.8B | $1.9B | $2B | $2B | |
Total Liabilities and Equity | $1.9B | $2.4B | $2.5B | $2.8B | $2.8B | |
Cash and Short Terms | $717.3M | $603.8M | $623.8M | $751.3M | $757.4M | |
Total Debt | $243.7M | $255.3M | $284.6M | $579.6M | $525.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $711.3M | $584.6M | $516.6M | $780.6M | $697.2M | |
Short Term Investments | -- | -- | $101.4M | -- | -- | |
Accounts Receivable, Net | $90.2M | $122.4M | $133.5M | $115.8M | $147.4M | |
Inventory | $109.5M | $213.8M | $244.7M | $198M | $153.1M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $15.3M | $23.9M | $22.6M | $37.6M | $34.7M | |
Total Current Assets | $926.3M | $944.8M | $1B | $1.1B | $1B | |
Property Plant And Equipment | $99.3M | $247.4M | $314.5M | $340.3M | $325.2M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $617.5M | $859.5M | $856.3M | $986M | $1.1B | |
Other Intangibles | $281.7M | $329.9M | $346.6M | $388.1M | $409.2M | |
Other Long-Term Assets | $529K | $631K | $1.2M | $956K | $2.1M | |
Total Assets | $1.9B | $2.4B | $2.5B | $2.8B | $2.9B | |
Accounts Payable | $20.6M | $38.3M | $26.4M | $18.7M | $26.9M | |
Accrued Expenses | $12.9M | $15.5M | $16.3M | $19M | $21.9M | |
Current Portion Of Long-Term Debt | $246.6M | $283.3M | $285.1M | $69.5M | -- | |
Current Portion Of Capital Lease Obligations | $3.8M | $9.9M | $8M | $9.8M | $15.2M | |
Other Current Liabilities | -- | $27.8M | $27.8M | $24.4M | $42.1M | |
Total Current Liabilities | $313.3M | $424.3M | $405.3M | $178.3M | $152M | |
Long-Term Debt | -- | -- | -- | $513.9M | $529.6M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $371.1M | $617.4M | $597.7M | $878.7M | $866.7M | |
Common Stock | $549K | $554K | $556K | $559K | $562K | |
Other Common Equity Adj | -$7.5M | -$21.6M | -$31.1M | -$42.7M | -$47.8M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $1.6B | $1.8B | $1.9B | $2B | $2B | |
Total Liabilities and Equity | $1.9B | $2.4B | $2.5B | $2.8B | $2.9B | |
Cash and Short Terms | $711.3M | $584.6M | $618M | $780.6M | $697.2M | |
Total Debt | $246.6M | $283.3M | $285.1M | $583.4M | $529.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $59.9M | $128.3M | $186M | $35.6M | -$25.5M | |
Depreciation & Amoritzation | $27.1M | $38.4M | $57M | $86.1M | $86.6M | |
Stock-Based Compensation | $17M | $27.5M | $27.3M | $25.6M | $48.1M | |
Change in Accounts Receivable | -$20.9M | -$46.5M | -$3.6M | -$3.3M | -$14M | |
Change in Inventories | -$30M | -$89.8M | -$57.2M | $41M | $56.9M | |
Cash From Operations | $62.6M | $119M | $172.1M | $113.9M | $175.4M | |
Capital Expenditures | $26.3M | $71.3M | $133.3M | $39M | $32.9M | |
Cash Acquisitions | -$175M | -$149.9M | -- | -$186.6M | -$54.8M | |
Cash From Investing | -$201.4M | -$221.2M | -$233.2M | -$123.3M | -$86.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $290.1M | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -$69.9M | |
Repurchase of Common Stock | -- | -- | -- | -$14.4M | -- | |
Other Financing Activities | -$10K | -$2.9M | -$17M | -$27.8M | -$17.3M | |
Cash From Financing | $305.9M | $961K | -$13.3M | $249M | -$82.9M | |
Beginning Cash (CF) | $537.4M | $717.3M | $603.8M | $523.5M | $751.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $167.2M | -$101.2M | -$74.5M | $239.6M | $6.1M | |
Ending Cash (CF) | $717.3M | $603.8M | $523.5M | $751.3M | $757.4M | |
Levered Free Cash Flow | $36.3M | $47.7M | $38.7M | $74.9M | $142.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $29.5M | $47M | $15.3M | $3.3M | $5.8M | |
Depreciation & Amoritzation | $8.4M | $11.8M | $15.4M | $21.3M | $23.2M | |
Stock-Based Compensation | $6.5M | $7.9M | $7.3M | $8.8M | $7.3M | |
Change in Accounts Receivable | -$19.8M | -$6.3M | -$16.8M | $6.7M | -$9.9M | |
Change in Inventories | -$17M | -$30M | -$5.8M | $3.2M | -$3.8M | |
Cash From Operations | $9.3M | $23.1M | $11.2M | $44.7M | $15M | |
Capital Expenditures | $9.1M | $28.2M | $9.4M | $8.4M | $4.4M | |
Cash Acquisitions | $71K | -- | -- | -- | -$69.7M | |
Cash From Investing | -$9M | -$28.2M | -$9.4M | -$8.4M | -$74.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$1K | -$6K | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -$12.3M | -$9.6M | -$9.9M | -$6.5M | |
Cash From Financing | $507K | -$12M | -$9.6M | -$9M | -$5M | |
Beginning Cash (CF) | $717.3M | $603.8M | $523.5M | $751.3M | $757.4M | |
Foreign Exchange Rate Adjustment | -$6.7M | -$2.1M | $993K | $1.9M | $4M | |
Additions / Reductions | $772K | -$17.1M | -$7.8M | $27.4M | -$64.1M | |
Ending Cash (CF) | $711.3M | $584.6M | $516.6M | $780.6M | $697.2M | |
Levered Free Cash Flow | $194K | -$5.1M | $1.7M | $36.3M | $10.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $79.6M | $145.8M | $154.3M | $23.6M | -$23M | |
Depreciation & Amoritzation | $29.1M | $41.8M | $60.5M | $92M | $88.4M | |
Stock-Based Compensation | $19.4M | $28.9M | $26.7M | $27.1M | $46.6M | |
Change in Accounts Receivable | -$38.4M | -$33M | -$14.2M | $20.2M | -$30.6M | |
Change in Inventories | -$39.8M | -$102.8M | -$33M | $50M | $49.9M | |
Cash From Operations | $62.4M | $132.9M | $160.1M | $147.5M | $145.7M | |
Capital Expenditures | $30.4M | $90.4M | $114.5M | $37.9M | $29M | |
Cash Acquisitions | -$175M | -$150M | -- | -$186.6M | -$124.5M | |
Cash From Investing | -$205.3M | -$240.4M | -$214.5M | -$122.2M | -$152.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$1K | -$5K | $6K | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -$14.3M | -$28.2M | -$13.8M | |
Cash From Financing | $304.8M | -$11.6M | -$10.9M | $249.6M | -$79M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $161.8M | -$119.1M | -$65.2M | $274.8M | -$85.4M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $32M | $42.4M | $45.6M | $109.5M | $116.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $29.5M | $47M | $15.3M | $3.3M | $5.8M | |
Depreciation & Amoritzation | $8.4M | $11.8M | $15.4M | $21.3M | $23.2M | |
Stock-Based Compensation | $6.5M | $7.9M | $7.3M | $8.8M | $7.3M | |
Change in Accounts Receivable | -$19.8M | -$6.3M | -$16.8M | $6.7M | -$9.9M | |
Change in Inventories | -$17M | -$30M | -$5.8M | $3.2M | -$3.8M | |
Cash From Operations | $9.3M | $23.1M | $11.2M | $44.7M | $15M | |
Capital Expenditures | $9.1M | $28.2M | $9.4M | $8.4M | $4.4M | |
Cash Acquisitions | $71K | -- | -- | -- | -$69.7M | |
Cash From Investing | -$9M | -$28.2M | -$9.4M | -$8.4M | -$74.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$1K | -$6K | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -$12.3M | -$9.6M | -$9.9M | -$6.5M | |
Cash From Financing | $507K | -$12M | -$9.6M | -$9M | -$5M | |
Beginning Cash (CF) | $717.3M | $603.8M | $523.5M | $751.3M | $757.4M | |
Foreign Exchange Rate Adjustment | -$6.7M | -$2.1M | $993K | $1.9M | $4M | |
Additions / Reductions | $772K | -$17.1M | -$7.8M | $27.4M | -$64.1M | |
Ending Cash (CF) | $711.3M | $584.6M | $516.6M | $780.6M | $697.2M | |
Levered Free Cash Flow | $194K | -$5.1M | $1.7M | $36.3M | $10.6M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.